Literature DB >> 22884857

Quantification of seven β-lactam antibiotics and two β-lactamase inhibitors in human plasma using a validated UPLC-MS/MS method.

Mieke Carlier1, Veronique Stove, Jason A Roberts, Eric Van de Velde, Jan J De Waele, Alain G Verstraete.   

Abstract

There is an increasing interest in monitoring plasma concentrations of β-lactam antibiotics. The objective of this work was to develop and validate a rapid ultra-performance liquid chromatographic method with tandem mass spectrometric detection (UPLC-MS/MS) for simultaneous quantification of amoxicillin, ampicillin, cefuroxime, cefazolin, ceftazidime, meropenem, piperacillin, clavulanic acid and tazobactam. Sample clean-up included protein precipitation with acetonitrile and back-extraction of acetonitrile with dichloromethane. Six deuterated β-lactam antibiotics were used as internal standards. Chromatographic separation was performed on a Waters ACQUITY UPLC system using a BEH C(18) column (1.7 μm, 100 mm×2.1 mm) applying a binary gradient elution of water and acetonitrile both containing 0.1% formic acid. The total run time was 5.5 min. The developed method was validated in terms of precision, accuracy, linearity, matrix effect and recovery. The assay has now been successfully used to determine concentrations of amoxicillin/clavulanic acid, cefuroxime and meropenem in plasma samples from intensive care patients.
Copyright © 2012 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22884857     DOI: 10.1016/j.ijantimicag.2012.06.022

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  16 in total

1.  Therapeutic drug monitoring-based dose optimisation of piperacillin and meropenem: a randomised controlled trial.

Authors:  Jan J De Waele; S Carrette; M Carlier; V Stove; J Boelens; G Claeys; I Leroux-Roels; E Hoste; P Depuydt; J Decruyenaere; A G Verstraete
Journal:  Intensive Care Med       Date:  2013-12-20       Impact factor: 17.440

2.  Therapeutic drug monitoring of piperacillin and tazobactam by RP-HPLC of residual blood specimens.

Authors:  Sylvia M Verhoven; Joseph J Groszek; William H Fissell; Adam Seegmiller; Jennifer Colby; Pratish Patel; Alain Verstraete; Matthew Shotwell
Journal:  Clin Chim Acta       Date:  2018-03-26       Impact factor: 3.786

3.  A Dual-Biotic System for the Concurrent Delivery of Antibiotics and Probiotics: In Vitro, Ex Vivo, In Vivo and In Silico Evaluation and Correlation.

Authors:  Mershen Govender; Yahya E Choonara; Sandy van Vuuren; Pradeep Kumar; Lisa C du Toit; Kennedy Erlwanger; Viness Pillay
Journal:  Pharm Res       Date:  2016-09-06       Impact factor: 4.200

4.  Simultaneous Determination of Eight β-Lactam Antibiotics, Amoxicillin, Cefazolin, Cefepime, Cefotaxime, Ceftazidime, Cloxacillin, Oxacillin, and Piperacillin, in Human Plasma by Using Ultra-High-Performance Liquid Chromatography with Ultraviolet Detection.

Authors:  Tiphaine Legrand; Dominique Vodovar; Nicolas Tournier; Nihel Khoudour; Anne Hulin
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

5.  Development of a Novel Multipenicillin Assay and Assessment of the Impact of Analyte Degradation: Lessons for Scavenged Sampling in Antimicrobial Pharmacokinetic Study Design.

Authors:  Karin Kipper; Charlotte I S Barker; Joseph F Standing; Mike Sharland; Atholl Johnston
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

Review 6.  How do we use therapeutic drug monitoring to improve outcomes from severe infections in critically ill patients?

Authors:  Gloria Wong; Fekade Bruck Sime; Jeffrey Lipman; Jason A Roberts
Journal:  BMC Infect Dis       Date:  2014-11-28       Impact factor: 3.090

7.  An Approach to Transfer Methods from HPLC to UHPLC Techniques in Some Carbapenems.

Authors:  Przemysław Zalewski; Alicja Talaczyńska; Patrycja Korban; Piotr Garbacki; Mikołaj Mizera; Judyta Cielecka-Piontek
Journal:  Chromatographia       Date:  2014-08-17       Impact factor: 2.044

8.  Individualization of piperacillin dosing for critically ill patients: dosing software to optimize antimicrobial therapy.

Authors:  T W Felton; J A Roberts; T P Lodise; M Van Guilder; E Boselli; M N Neely; W W Hope
Journal:  Antimicrob Agents Chemother       Date:  2014-05-05       Impact factor: 5.191

9.  Simple and Robust Analysis of Cefuroxime in Human Plasma by LC-MS/MS: Application to a Bioequivalence Study.

Authors:  Xingjiang Hu; Mingzhu Huang; Jian Liu; Junchun Chen; Jianzhong Shentu
Journal:  Adv Pharmacol Sci       Date:  2014-04-24

10.  Augmented renal clearance implies a need for increased amoxicillin-clavulanic acid dosing in critically ill children.

Authors:  Pieter A J G De Cock; Joseph F Standing; Charlotte I S Barker; Annick de Jaeger; Evelyn Dhont; Mieke Carlier; Alain G Verstraete; Joris R Delanghe; Hugo Robays; Peter De Paepe
Journal:  Antimicrob Agents Chemother       Date:  2015-09-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.